Data: 08/08/2026
Total encontrado: 21
1/21US=9 / Urologia
Fojo AT, Adelberg DE. Microtubule targeting agents. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 179-94. ISBN 978-1-60327-831-7.

CITOESQUELETO; MICROTUBULOS; TUBULINA; QUIMIOTERAPIA; CANCER DE PROSTATA

2/21US=21 / Biol/Mol
Hamel E. An overview of compounds that interact with tubulin and their effects on microtubule assembly. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 1-19. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

TUBULINA; LOCAL TAXOIDE; LADO LAULIMALIDE; ALQUILACAO TUBULINA; SITE DE COLCHICINA; VINCER DOMINIO

3/21US=21 / Biol/Mol
Correia JJ, Lobert S. Molecular mechanisms of microtubule acting cancer drugs. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 21-46. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

MECANISMOS MOLECULARES DE MICROTUBULOS; CANCER; REGULACAO ALOSTERICA; ANTIMITOTICOS; CINETICA; MICROTUBULOS; POLIMEROS; TERMODINAMICA; TUBULINA

4/21US=21 / Biol/Mol
Kavallaris M, Don S, Verrills NM. Microtubule-associated proteins and microtubule-interracting proteins. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 83-104. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

MICROTUBULOS; TUBULINA; MICROTUBULOS PROTEINAS ASSOCIADAS; STATHMIN; ESTABILIDADE DOS MICROTUBULOS

5/21US=21 / Biol/Mol
Ludueña RF, Banerjee A. The post-translational modifications of tubulin. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 105-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

MODIFICACOES POS-TRADUCIONAIS DE TUBULINA; TUBULINA; &*945;-TUBULINA; &*946;-TUBULINA; MODIFICACAO POS-TRADUCAO; FOSFORILACAO; ACETILACAO; TYROSINOLATION; POLYGLYTAMATION; POLYGLYCYLATION; DEGLUTAMYLATION

6/21US=21 / Biol/Mol
Ludueña RF, Banerjee A. The isotypes of tubulin. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 123-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

OS ISOTIPOS DE TUBULINA; TUBILIN; &*945;-TUBILIN; &*946;-TUBILIN; &*946;I; &*946;II; &*946;III; &*946;IV; &*946;V; &*946;VI; ISITYPES; DROGAS ANTI-TUMORAIS; EVOLUCAO; AXONEMES; CILIOS; FLAGELOS

7/21US=21 / Biol/Mol
Ludueña RF, Banerjee A. The tubulin superfamily. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 177-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

SUPERFAMILIA TUBULINA; TUBILIN; &*945;-TUBILIN; &*946;-TUBILIN; &*947;-TUBILIN; &*949;-TUBILIN; &*951;-TUBILIN; &*948;-TUBILIN; EVOLUCAO; CENTRIOLO; CENTROSSOMA; BASAL DO CORPO

8/21US=21 / Biol/Mol
Verdier-Pinerd P, Wang F, Angeletti RH, Horwitz SB, Orr GA. Tubulin proteomics in cancer. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 193-210. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

PROTEOMICA TUBULINA EM CANCER; MICROTUBULOS; PROTEOMICA; MALDI-TOF MS; ESI MS; IEF

9/21US=21 / Biol/Mol
Nogales E, Downing KH. Tubulin and microtubule structures. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 211-25. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

ESTRUTURAS DE TUBULINA E DE MICROTUBULOS; TUBULINA; MICROTUBULOS; INSTABILIDADE DINAMICA; ANTI-MITOTICOS AGENTES; TAXOL; EPOTILONA; GTPASE

10/21US=21 / Biol/Mol
Greenberger LM, Loganzo F. Destabilizing agents. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 227-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

AGENTES DESESTABILIZADORES; DOLASTATINAS; CRIPTOFICINAS; HEMIASTERLINS; PHOMOPSIN; USILOXINS; DIAZONAMIDES; TUBULYSINS; VITILEVUAMIDE; TUBULINA; VINBLASTINA

11/21US=21 / Biol/Mol
Bane SL. Molecular features of the interaction of colchicine and related structures with tubulin. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 259-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

ANTIMITOTICO; COLCHICINA; COMBRETASTATINA; MECANISMO; MICROTUBULOS; POSOPHYLLOTOXIN; RELACOES ESTRUTURA-ACTIVIDADE; TUBULINA

12/21US=21 / Biol/Mol
Sackett DL. Antimicrotubule agents that bind covalently to tubulin. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 281-306. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

AGENTES ANTIMICROTUBULO; TUBULINA; SULFIDRILA; CISTEINA; METAIS PESADOS; MERCURIO; CISPLATINA; LISINA

13/21US=21 / Biol/Mol
Horwitz SB, Fojo T. Microtubule stabilizing agents. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 307-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

AGENTES ESTABILIZADORES DE MICROTUBULOS; ESTABILIZADORES DE MICROTUBULOS, AGENTES; PACLITAXEL; TAXOTERE; EPOTILONAS; DISCODERMOLIDE; MICROTUBULOS; TUBULINA

14/21US=21 / Biol/Mol
Cabral F. Mechanisms of resistance to drugs that interfere with microtubule assembly. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 337-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

MECANISMOS DE RESISTENCIA A DROGAS QUE INTERFEREM COM A MONTAGEM DE MICROTUBULOS; RESISTENCIA A DROGAS; PACLITAXEL; COLCEMIDA; VINBLASTINA; TUBULINA; MUTACOES; ISOTIPOS

15/21US=21 / Biol/Mol
Giannakakau P, Snyder JP. Resistance to microtubule-targeting drugs. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 357-94. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0.

RESISTENCIA A DROGAS DE MICROTUBULOS SEGMENTACAO; MICROTUBULOS; RESISTENCIA AS DROGAS; TAXANOS; ALCALOIDES DA VINCA; COLCHICINA; MUTACAO TUBULINA

16/21US=3 / Química
Voet D, Voet JG, Pratt CW. Função das proteínas, parte II: proteínas motoras e do citoesqueleto e anticorpos. In: ___. Fundamentos de bioquímica: a vida em nível molecular. 2ª ed. Rio de Janeiro: Elsevier, 2008. p. 1072-159. ISBN 85-3631347-4.

ACTINA; MICROFILAMENTOS; CONTRACAO MUSCULAR; TUBULINA; MICROTUBULOS; MOTORES DE MICROTUBULOS; ANTICORPOS; ANTICORPOS MONOCLONAIS; DOENCAS AUTO-IMUNES

17/21US=47 / Câncer
Toyota M, Kashima L, Tokino T. CHFR as a potential anticancer target. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 163-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

CHFR; AGENTE ANTICANCERIGENO; CHECKPOINT MITOTICO; CHECKPOINT PROFASE; TUBULINA; UBIQUITINA LIGASE E3; MITOSE

18/21US=47 / Câncer
Villalona-Calero MA, Schaaf L, Turowski R. Antimicrotubule agents. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 177-205. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7.

AGENTES ANTIMICROTUBULOS; TUBULINA; ALCALOIDES DA VINCA; TAXANOS; EPOTILONAS; RESISTENCIA TUMOR; ALBUMINA

19/21US=67 / Biol/Mol
Heath EI, Carducci MA. Targeted therapies for prostate cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 263-90. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4.

CANCER DE PROSTATA; TERAPIA-ALVO; INIBIDORES DA VIA DE SINALIZACAO; INIBIDORES DA ANGIOGENESE; IMUNOTERAPIA; AGENTES ANTI-TUBULINA; AGENTES ANTI-MITOTICOS; AGENTES DE SEGMENTACAO ANTI-VASCULARES

20/21US=773 / Tese/FAP
Oliveira TB. Impacto prognóstico de células tumorais circulantes e potencial papel preditor de resposta ao tratamento em carcinoma epidermóide de cabeça e pescoço localmente avançado. [Prognostic impact and potential predictive role of circulating tumor cells in locally advanced head and neck squamous cell carcinoma]. São Paulo, 2019. 157 p. Tese(Doutorado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2019/TBOliveira/TBOliveira.pdf

Curriculum Lattes

CELULAS NEOPLASICAS CIRCULANTES; NEOPLASIAS DE CABECA E PESCOCO; CARCINOMA DE CELULAS ESCAMOSAS. TERAPIA; BIOMARCADORES TUMORAIS

Primeira | Anterior | Próxima | Última